Keytruda Awareness

In Memory of Michael Adam Garrick

I write this for you, friend I’ve never met, to mark the trail through the Dark Woods so that you might discern the way you should go. I wish there had been a blog like this for my dad to read when he sat down at his desk — I can see him now in the early morning with his thick white socks on, opening up his Yahoo webpage to do his Internet search: “Keytruda side effects.” I’m sure he would’ve found this blog, and read it, and changed his mind. 

Keytruda QLEX™ (Pembrolizumab) Killed My Dad in 58 Days
Read More

Data is scarce on melanoma patients over 75. From what I can tell, Merck Pharmaceuticals has not conducted a dedicated, standalone phase 3 clinical trial exclusively for elderly melanoma patients; rather, efficacy and safety data are derived from subgroup analyses of landmark trials (such as KEYNOTE-006) and large retrospective/real-world cohort studies. The risk for this population is high.

ARTICLE COMING SOON 
What You Need to Know about Keytruda (Pembrolizumab)and the Elderly Population (> 65 years)